Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is an active Phase 2 interventional trial with no results posted; the registry record describes planned enrollment and primary outcome measures only, representing early-stage evaluation of a novel radiosensitizer in brain metastases.
This is a Phase 1/2 trial registration with no results posted; the study is actively recruiting and designed to assess safety in a dose-escalation format across multiple solid tumor types.
Phase 1 study registration with no posted results; designed to evaluate PK similarity and safety of a biosimilar candidate versus reference comparator in early-stage oncology patients.
This is an ongoing observational screening registry with no posted results; it describes planned enrollment and evaluation procedures for experimental immunotherapy protocols, not outcome data.
Phase 1 dose escalation and expansion trial with no results posted; registry record describes planned safety and efficacy assessment in advanced solid tumors but contains no outcome data.
This is a registry record for an ongoing observational cell-harvesting study with no reported results; it describes planned enrollment and procedural outcomes only, not clinical efficacy or safety data.
This is a Phase 2 proof-of-concept study registration with no results reported; the trial is actively recruiting and designed to explore HER3-DXd monotherapy across multiple solid tumor types.
This is a clinical trial registry record for a planned observational screening study with no results posted; it describes study design and eligibility criteria only.